UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):      August 5, 2013

PAULSON CAPITAL CORP.

(Exact name of registrant as specified in its charter)

Commission File Number: 000-18188

Oregon	93-0589534
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

1331 N.W. Lovejoy Street, Suite 720, Portland, Oregon	97209
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: 503-243-6000 

Former name or former address if changed since last report: 811 SW Naito Parkway, Suite 300, Portland, OR 97204 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

As previously reported, on July 27, 2013, Steve H. Kleemann, a member of the Board of Directors and Audit Committee of Paulson Capital Corp., died.

On July 29, 2013, Paulson notified NASDAQ that as a result of Mr. Kleemann’s death, Paulson is no longer in compliance with certain NASDAQ listing requirements, including the Majority Independent Board requirement (Listing Rule 5605(b)(1)) and the Audit Committee composition requirement (Listing Rule 5605(c)(2)). 

On August 5, 2013, Paulson received a deficiency letter from NASDAQ acknowledging Paulson’s non-compliance with Listing Rule 5605. NASDAQ’s letter further provided that, consistent with Listing Rules 5605(b)(1)(A) and 5605(c)(4), Paulson will have the following cure period to regain compliance: (i) until the earlier of Paulson’s next annual shareholders’ meeting or July 27, 2014; or (ii) if the next annual shareholders’ meeting is held before January 23, 2014, then Paulson must evidence compliance no later than January 23, 2014. Because Paulson’s next annual shareholders’ meeting will be held prior to January 23, 2014, Paulson intends to regain compliance prior to January 23, 2014.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	PAULSON CAPITAL CORP.
Date: August 6, 2013	By:	/s/ Chester L. F. Paulson
		Chester L. F. Paulson
		President and Chief Executive Officer